PMID: 9539303Apr 16, 1998Paper

Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine

European Journal of Endocrinology
Michele De RosaG Lombardi

Abstract

This study evaluated the effects of chronic treatment with cabergoline (CAB), a new, potent and long-lasting ergoline-derived dopamine agonist, on seminal fluid parameters and sexual and gonadal function in hyperprolactinemic males in comparison with the effect of bromocriptine (BRC) treatment. Seventeen males with macroprolactinoma were treated with CAB at a dose of 0.5-1.5 mg/week (n = 7), or BRC at a dose of 5-15 mg/day (n = 10) for 6 months. Baseline prolactin (PRL) was 925.7 +/- 522.6 microg/l in the CAB-treated group and 1059.4 +/- 297.6 microg/l in the BRC-treated group. All the patients suffered from libido impairment, ten from reduced sexual potency, and six had infertility. In five patients provocative bilateral galactorrhea was found. Seminal fluid analysis, functional seminal tests and penis rigidity and tumescence, measured by nocturnal penile tumescence (NPT) using Rigiscan equipment, were assessed before and after 1, 3 and 6 months of CAB or BRC treatment. Hormone profiles were assessed before and after 15, 30, 60, 90 and 180 days of both treatments. Before treatment, all patients had a low sperm count with oligoasthenospermia, reduced motility and rapid progression with an abnormal morphology and decreased viabi...Continue Reading

Citations

Nov 10, 1998·Lancet·A Colao, G Lombardi
Feb 12, 2002·Neuroscience and Biobehavioral Reviews·Tillmann H C KrügerMichael S Exton
Feb 13, 2001·Psychoneuroendocrinology·M S ExtonM Schedlowski
Feb 16, 2000·Psychoneuroendocrinology·N G ExtonM Schedlowski
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Annamaria ColaoGaetano Lombardi
Jan 19, 2011·Nature Reviews. Urology·Kathleen HwangLarry I Lipshultz
Sep 24, 2011·Current Opinion in Urology·Alexander Bolyakov, Darius A Paduch
Jul 26, 2012·Systematic Reviews·Amy T WangMohammad Hassan Murad
Jun 12, 2004·Neurosurgical Focus·James K Liu, William T Couldwell
Sep 28, 2012·Journal of Endocrinological Investigation·M GaldieroA Colao
Jan 18, 2006·Pituitary·Antonio CiccarelliAnnamaria Colao
May 13, 2005·World Journal of Urology·Tillmann H C KrügerManfred Schedlowski
May 31, 2002·Expert Opinion on Investigational Drugs·Annamaria ColaoGaetano Lombardi
Nov 30, 2013·The Urologic Clinics of North America·Boback M Berookhim, Peter N Schlegel
Dec 1, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Annamaria Colao
Feb 9, 2016·Expert Opinion on Drug Safety·Renata S AuriemmaAnnamaria Colao
Jan 30, 2008·Endocrinology and Metabolism Clinics of North America·Tatiana ManciniAndrea Giustina
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Irwin Goldstein
Apr 18, 2003·Clinical Endocrinology·S M CorselloC Colosimo
Sep 12, 2013·Physiology & Behavior·Milene Leivas VieiraDaniela Cristina Ceccatto Gerardin
Nov 14, 1998·Annals of Medicine·A ColaoG Lombardi
Mar 16, 2001·Expert Opinion on Pharmacotherapy·A ColaoL Annunziato
Nov 6, 2012·Expert Opinion on Pharmacotherapy·Alaa J HamadaAshok Agarwal
Mar 23, 2011·Nature Reviews. Endocrinology·Annamaria Colao, Silvia Savastano
Sep 10, 2014·Urologia·Gaetano GulinoPier Francesco Bassi
Oct 1, 2016·Medwave·Nicolás TriantafiloGabriel Rada
Mar 9, 2018·Endocrine Connections·Mikkel AndreassenNiels Jørgensen
Sep 22, 2000·The Journal of Clinical Endocrinology and Metabolism·J J PinzoneA Klibanski
Feb 16, 2005·Reviews in Endocrine & Metabolic Disorders·David M Cook
May 2, 2018·Arab Journal of Urology·Zeinab Dabbous, Stephen L Atkin
May 1, 2008·Expert Review of Endocrinology & Metabolism·Marcello D Bronstein
May 11, 2018·American Journal of Therapeutics·Robert Krysiak, Bogusław Okopień
Nov 20, 2019·Clinical and Experimental Reproductive Medicine·Seung-Hun SongDong Suk Kim
May 18, 2006·Endocrine Reviews·Mary P GillamAnnamaria Colao
Jul 15, 1999·The Journal of Clinical Endocrinology and Metabolism·J VerhelstA Beckers
Sep 1, 2012·Journal of Endocrinological Investigation·M GaldieroA Colao
Feb 6, 2004·Arquivos de neuro-psiquiatria·Gisele Rieffel BraucksAlice Helena Dutra Violante

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.